Should you buy EYPT stock?
Last updated:
Based on market data through , StockInvest.us rates EyePoint Pharmaceuticals Inc. (EYPT) as Hold/Accumulate with a technical score of -0.68 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.
- Hold signal since
- Price since signal Up 6.69%
- 3-month trend forecast Up 0.49%
- Easy Tracking In The Watchlist
EyePoint Pharmaceuticals Inc. stock price took a fall of -5.90% on Monday
(Market data through Aug 10, 2026)
The EyePoint Pharmaceuticals Inc. stock price fell by -5.90% on the last day (Monday, 10th Aug 2026) from $13.89 to $13.07. During the last trading day the stock fluctuated 9.98% from a day low at $13.02 to a day high of $14.32. The price has been going up and down for this period, and there has been a 5.32% gain for the last 2 weeks. Volume has increased on the last day by 106 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 million shares were bought and sold for approximately $22.70 million.
The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect EyePoint Pharmaceuticals Inc. stock with a 90% probability to be traded between $11.56 and $14.94 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.
EYPT Signals & Forecast
There are mixed signals in the stock today. The EyePoint Pharmaceuticals Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $13.32. On a fall, the stock will find some support from the short-term average at $12.63. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Friday, August 07, 2026, and so far it has fallen -5.90%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for EyePoint Pharmaceuticals Inc. stock
EyePoint Pharmaceuticals Inc. finds support from accumulated volume at $12.83 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.30 between high and low, or 9.98%. For the last week, the stock has had daily average volatility of 8.82%.
Our recommended stop-loss: $12.42 (-5.00%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 1 day ago.)
Trading Expectations (EYPT) For The Upcoming Trading Day Of Tuesday 11th
For the upcoming trading day on Tuesday, 11th we expect EyePoint Pharmaceuticals Inc. to open at $13.47, and during the day (based on 14 day Average True Range), to move between $12.59 and $13.55, which gives a possible trading interval of +/-$0.95 (+/-7.56%) up or down from last closing price. If EyePoint Pharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 7.56% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $13.15 (0.61%) than the support at $12.83 (1.84%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is EyePoint Pharmaceuticals Inc. stock A Buy?
EyePoint Pharmaceuticals Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Current score:
-0.676
Hold/Accumulate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on August 11, 2026 - $13.47 ( 3.06%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
EYPT Performance
Trading levels for EYPT
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 14.77 | 13.01% |
| R2 | 14.27 | 9.21% |
| R1 | 13.97 | 6.86% |
| Price | 13.07 | |
| S1 | 12.97 | -0.739% |
| S2 | 12.67 | -3.09% |
| S3 | 12.17 | -6.89% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 13.98 | 6.96% |
| R2 | 13.66 | 4.51% |
| R1 | 13.15 | 0.612% |
| Price | 13.07 | |
| S1 | 12.83 | -1.84% |
| S2 | 12.25 | -6.27% |
| S3 | 11.67 | -10.71% |
FAQ
Click here for our free guide on how to buy EyePoint Pharmaceuticals Inc. Stock.
Buy EYPT